Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China flag China · Delayed Price · Currency is CNY
15.65
-0.18 (-1.14%)
Apr 17, 2026, 12:55 PM CST

SHE:300233 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
826.03917.911,025859.13981.18
Trading Asset Securities
70----
Cash & Short-Term Investments
896.03917.911,025859.13981.18
Cash Growth
-2.38%-10.42%19.27%-12.44%-8.75%
Accounts Receivable
691.8696.8794.56803.39684
Other Receivables
3.236.297.814.625.08
Receivables
695.03703.09802.37808.01689.08
Inventory
464.61598.86501.28579.22391.32
Prepaid Expenses
--0.20.550.01
Other Current Assets
30.1638.4240.7761.2477.68
Total Current Assets
2,0862,2582,3692,3082,139
Property, Plant & Equipment
2,1482,3102,4682,4692,093
Long-Term Investments
181.84183.28147.52141.22143.31
Other Intangible Assets
545.61513.51547.29452.2449.75
Long-Term Deferred Tax Assets
47.663.9469.7751.9630.71
Long-Term Deferred Charges
147.98252.96310.89369.59329.72
Other Long-Term Assets
33.9323.53.5134.4289.77
Total Assets
5,1915,6055,9165,8265,275
Accounts Payable
498.19552.56824726.05515.31
Accrued Expenses
295.44355.9402.32394.98362.19
Short-Term Debt
120.0855.0494212.89223
Current Portion of Long-Term Debt
168.67101.52109.24163.2155.45
Current Portion of Leases
1.770.130.721.112.37
Current Income Taxes Payable
12.4121.5324.8518.8418.72
Current Unearned Revenue
40.7850.9432.7444.6754.47
Other Current Liabilities
84.7693.35112.47139.284.94
Total Current Liabilities
1,2221,2311,6001,7011,416
Long-Term Debt
85.52351.99346.7271.69208.29
Long-Term Leases
3.46.883.462.0263.52
Long-Term Unearned Revenue
45.2453.8861.66654.81
Long-Term Deferred Tax Liabilities
110.68129.1122.94126.2192.66
Total Liabilities
1,4671,7732,1352,1671,836
Common Stock
383.87383.87383.87387.41387.41
Additional Paid-In Capital
--2,3282,3972,404
Retained Earnings
943.381,051967.95850.41653.34
Treasury Stock
-55.01-55.01--56.94-80.01
Comprehensive Income & Other
2,3912,38734.6229.3329.44
Total Common Equity
3,6633,7673,7143,6073,394
Minority Interest
60.5865.1766.9351.8744.96
Shareholders' Equity
3,7243,8323,7813,6593,439
Total Liabilities & Equity
5,1915,6055,9165,8265,275
Total Debt
379.44515.56554.12650.91652.62
Net Cash (Debt)
516.59402.35470.54208.22328.55
Net Cash Growth
28.39%-14.49%125.98%-36.62%-50.66%
Net Cash Per Share
1.401.061.210.540.85
Filing Date Shares Outstanding
379.33379.33383.87383.1383.87
Total Common Shares Outstanding
379.33379.33383.87383.1383.87
Working Capital
863.751,027768.95607.21722.83
Book Value Per Share
9.669.939.689.428.84
Tangible Book Value
3,1183,2533,1673,1552,945
Tangible Book Value Per Share
8.228.588.258.247.67
Buildings
1,5391,4241,4061,3561,021
Machinery
2,4412,4142,2892,1521,671
Construction In Progress
3.3673.33148.97121.31332.32
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.